DR. JANE BARBOSA AYALA M.D. NPI 1093914681

NPI Information

  • NPI: 1093914681
  • Provider Name: DR. JANE BARBOSA AYALA, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 19272 STONE OAK PKWY
    SUITE 101
    SAN ANTONIO, TX
    ZIP 78258
  • Phone: (210) 265-8851

Map and Directions

Get Directions

NPI Details

DR. Jane Barbosa Ayala, M.D. is a rheumatology internal medicine in San Antonio, TX with 24 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Jane Barbosa Ayala, M.D. NPI is 1093914681. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

19272 STONE OAK PKWY
SUITE 101
SAN ANTONIO, TX
ZIP 78258-371
Phone: (210) 265-8851
Fax: (210) 265-8855

The NPI 1093914681 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Uric acid level, blood (HCPCS:84550)
  • Vitamin d-3 level (HCPCS:82306)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Rheumatoid factor level (HCPCS:86431)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of pneumococcal vaccine (HCPCS:G0009)
  • Antibody identification test for white blood cell antibodies (HCPCS:86021)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
  • Screening test for autoimmune disorder (HCPCS:86038)

The enumeration date for this NPI number is 7/13/2007 and was last updated on 9/22/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine01064100AINDIANANo
2207R00000XInternal MedicineM7836TEXASNo
3207RR0500XInternal MedicineRheumatologyM7836TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.